Mark W Nachtigal
Mechanisms of non-apoptotic cell death induced by novel glycolipid drugs effective in killing chemotherapy-resistant HGSOC

Marilyne Labrie
Identifying clinically relevant therapeutic vulnerabilities in ovarian tumors using novel preclinical models

Jack Webb
ULK1 is required for spheroid cell viability during metastatic transit in epithelial ovarian cancer

Anna P Nicolela
Metabolic influences of the ovarian cancer tumour microenvironment direct natural killer cell function

Kathleen Moore
MIRASOL: Phase III trial on MRIV (antibody drug congugate for FR-alpha high platinum resistant OvCa)